상세 보기
PHI-101, a Novel FLT3 TKI, Shows Clinical Efficacy in Relapsed/Refractory FLT3-Mutated AML
- Shin, Dong-Yeop;
- Yoon, Sung-Soo;
- Hong, Junshik;
- Lee, Je-Hwan;
- Jang, Jun-Ho;
- 외 17명
Citations
WEB OF SCIENCE
2Citations
SCOPUS
0- 제목
- PHI-101, a Novel FLT3 TKI, Shows Clinical Efficacy in Relapsed/Refractory FLT3-Mutated AML
- 저자
- Shin, Dong-Yeop; Yoon, Sung-Soo; Hong, Junshik; Lee, Je-Hwan; Jang, Jun-Ho; Cheong, June-won; Shin, Ho-Jin; Lee, Jeong-Ok; Lee, Yoo Jin; Ahn, Jae-Sook; Cho, Byoung-Sik; Kim, Hee-Je; Clarey, Joseph; Sung, Gi-Jun; Im, Jeejin; Nam, Ky-Youb; Han, June; Kim, Kyu-Tae; Yoon, Jeonghyeok; Nguyen, Bao; Li, Li; Small, Donald
- 발행일
- 2024-11-05
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 144
- 페이지
- 1495 ~ 1496